Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs.

Acta orthopaedica. Supplementum Pub Date : 2008-08-01
Jørgen Baas
{"title":"Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs.","authors":"Jørgen Baas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Revision arthroplasty is a challenging aspect of the otherwise quite successful area of joint replacement surgery. The instable interaction between implant and host bone has often initiated a destructive process of inflammation and osteolysis, rendering the revision site sclerotic and with insufficient bone stock. One way of dealing with this is to build up a bed of tightly packed morselized bone graft to support the revision implant in a procedure often referred to as impaction grafting. Fresh frozen morselized femoral head allograft is the gold standard material for impaction grafting of the large defects usually involved in revision arthroplasty. The clinical outcome does not match that of primary arthroplasties. Implant subsidence is greater, implant survival shorter, and the bone graft is often not incorporated into living bone. The studies constituting this thesis have investigated ways of improving early implant fixation and bone graft incorporation. All studies used the same experimental canine model of early fixation and osseointegration of uncemented implant components inserted into a bed of impacted bone graft. Study I compared bone grafted implants where the morselized allograft was used alone or had been added rhBMP-2, the bisphosphonate pamidronate or a combination of the two. The main object was to see wether the previously observed growth factor related accelerated allograft resorption could be counteracted by the addition of an anti-catabolic drug. The study also compared HA-coated and non-coated porous Ti implants. The untreated control implants had better mechanical fixation than all other treatment groups. RhBMP-2 raised the total metabolic turnover of bone within the allograft with a net negative result on implant fixation. Pamidronate virtually blocked bone metabolism, also when combined with rhBMP-2. The HA-coated implants had more than twice as good mechanical fixation and improved osseointegration compared to the corresponding Ti implants. Study II investigated the addition of a bovine bone matrix lyophilisate (Colloss) to the allograft in three different doses. The main object was to see, whether the addition of a biological delivery device of low-dose osteogenic growth factors could provide a sufficient signal to increase the bioactivity of the bone graft without also yielding mechanical instability through increased allograft resorption. Allograft resorption increased with increased signal dose, but not to the extent that it affected implant fixation negatively at the observational time point. Mechanical implant fixation was doubled, and implant osseointegration and graft incorporation were improved. Study III compared a beta-TCP ceramic bone graft substitute (Ossaplast) with and without an osteogenic signal (Colloss E) to morselized allograft with and without the same signal. The object was to investigate, whether the addition of an osteogenic stimulus to a bio ceramic could replace biological allograft bone. The addition of an osteogenic signal improved early osseointegration of implants grafted with beta-TCP granules and increased their mechanical implant fixation to a level comparable to the allografted implants. All studies I-III confirmed that the topical addition of an osteogenic signal could increase implant osseointegration and the formation of new bone within a grafted defect. Another striking observation was the near-complete absence of fibrous tissue in the treated groups. The osseointegration of ceramic bone grafts improves when both the osteoconductive as well as the osteogenic components of bone are substituted. The effect on implant fixation of devices and pharmaceuticals that influence bone metabolism can be difficult to predict, as shown in study I. There seems to be a therapeutic window for these substances. This must be further explored prior to clinical use, as the adverse effects of overdosing bone anabolic and anti-catabolic substances can be detrimental.</p>","PeriodicalId":87168,"journal":{"name":"Acta orthopaedica. Supplementum","volume":"79 330","pages":"1-43"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta orthopaedica. Supplementum","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Revision arthroplasty is a challenging aspect of the otherwise quite successful area of joint replacement surgery. The instable interaction between implant and host bone has often initiated a destructive process of inflammation and osteolysis, rendering the revision site sclerotic and with insufficient bone stock. One way of dealing with this is to build up a bed of tightly packed morselized bone graft to support the revision implant in a procedure often referred to as impaction grafting. Fresh frozen morselized femoral head allograft is the gold standard material for impaction grafting of the large defects usually involved in revision arthroplasty. The clinical outcome does not match that of primary arthroplasties. Implant subsidence is greater, implant survival shorter, and the bone graft is often not incorporated into living bone. The studies constituting this thesis have investigated ways of improving early implant fixation and bone graft incorporation. All studies used the same experimental canine model of early fixation and osseointegration of uncemented implant components inserted into a bed of impacted bone graft. Study I compared bone grafted implants where the morselized allograft was used alone or had been added rhBMP-2, the bisphosphonate pamidronate or a combination of the two. The main object was to see wether the previously observed growth factor related accelerated allograft resorption could be counteracted by the addition of an anti-catabolic drug. The study also compared HA-coated and non-coated porous Ti implants. The untreated control implants had better mechanical fixation than all other treatment groups. RhBMP-2 raised the total metabolic turnover of bone within the allograft with a net negative result on implant fixation. Pamidronate virtually blocked bone metabolism, also when combined with rhBMP-2. The HA-coated implants had more than twice as good mechanical fixation and improved osseointegration compared to the corresponding Ti implants. Study II investigated the addition of a bovine bone matrix lyophilisate (Colloss) to the allograft in three different doses. The main object was to see, whether the addition of a biological delivery device of low-dose osteogenic growth factors could provide a sufficient signal to increase the bioactivity of the bone graft without also yielding mechanical instability through increased allograft resorption. Allograft resorption increased with increased signal dose, but not to the extent that it affected implant fixation negatively at the observational time point. Mechanical implant fixation was doubled, and implant osseointegration and graft incorporation were improved. Study III compared a beta-TCP ceramic bone graft substitute (Ossaplast) with and without an osteogenic signal (Colloss E) to morselized allograft with and without the same signal. The object was to investigate, whether the addition of an osteogenic stimulus to a bio ceramic could replace biological allograft bone. The addition of an osteogenic signal improved early osseointegration of implants grafted with beta-TCP granules and increased their mechanical implant fixation to a level comparable to the allografted implants. All studies I-III confirmed that the topical addition of an osteogenic signal could increase implant osseointegration and the formation of new bone within a grafted defect. Another striking observation was the near-complete absence of fibrous tissue in the treated groups. The osseointegration of ceramic bone grafts improves when both the osteoconductive as well as the osteogenic components of bone are substituted. The effect on implant fixation of devices and pharmaceuticals that influence bone metabolism can be difficult to predict, as shown in study I. There seems to be a therapeutic window for these substances. This must be further explored prior to clinical use, as the adverse effects of overdosing bone anabolic and anti-catabolic substances can be detrimental.

非胶结骨植入体周围骨移植辅助治疗方法及犬体力学实验。
在关节置换术中,翻修关节置换术是一个具有挑战性的方面。植入物和宿主骨之间不稳定的相互作用通常会引发破坏性的炎症和骨溶解过程,导致翻修部位硬化和骨储存不足。处理这个问题的一种方法是在通常被称为嵌塞移植的过程中建立一个紧密堆积的片状骨移植物床来支持修复种植体。新鲜冷冻碎状同种异体股骨头移植物是修复关节置换术中常见的大缺损内嵌移植术的金标准材料。临床结果与原发性关节置换术不一致。种植体下沉较大,种植体存活时间较短,骨移植物往往不能融入活骨。本论文的研究旨在探讨改善早期种植体固定和骨植入的方法。所有的研究都使用了相同的实验犬模型,将未胶结的种植体部件插入到阻生骨移植床中进行早期固定和骨整合。研究1比较了单独使用同种异体块化移植物或添加rhBMP-2、双膦酸盐帕米膦酸盐或两者联合使用的骨移植植入物。主要目的是观察先前观察到的生长因子相关的异体移植物加速吸收是否可以通过添加抗分解代谢药物来抵消。该研究还比较了ha涂层和非涂层多孔钛植入物。对照种植体的机械固定效果优于其他治疗组。RhBMP-2提高了同种异体移植物内骨的总代谢转换,对移植物固定产生净负作用。帕米膦酸盐实际上阻断了骨代谢,当与rhBMP-2联合使用时也是如此。与相应的钛种植体相比,ha涂层种植体具有两倍以上的良好机械固定和更好的骨整合。研究二研究了在三种不同剂量的同种异体移植物中加入牛骨基质冻干液(Colloss)。主要目的是观察添加低剂量成骨生长因子的生物递送装置是否能够提供足够的信号来增加骨移植物的生物活性,同时又不会通过增加同种异体移植物的吸收而产生机械不稳定性。同种异体移植物吸收随信号剂量的增加而增加,但在观察时间点未达到负面影响植入物固定的程度。机械种植体固定加倍,种植体骨整合和移植物结合得到改善。研究III比较了具有和不具有成骨信号(Colloss E)的β - tcp陶瓷骨移植替代物(Ossaplast)与具有和不具有相同信号的碎片化同种异体移植物。目的是研究在生物陶瓷中加入成骨刺激是否可以替代同种异体生物骨。成骨信号的加入改善了β - tcp颗粒植入物的早期骨整合,并将其机械植入物固定提高到与同种异体移植植入物相当的水平。所有研究I-III均证实,局部添加成骨信号可增加种植体骨整合和移植缺损内新骨的形成。另一个引人注目的观察结果是在治疗组中几乎完全没有纤维组织。当骨的导骨成分和成骨成分同时被替换时,陶瓷骨移植物的骨整合性得到改善。如研究1所示,影响骨代谢的器械和药物对植入物固定的影响很难预测。这些物质似乎有一个治疗窗口期。这必须在临床使用前进一步探讨,因为过量的骨合成代谢和抗分解代谢物质的不良影响可能是有害的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信